carotid intima media

Related by string. Carotid Intima Media * Carotid : carotid artery stenosis . asymptomatic carotid stenosis . Lickliter carotid artery . Zednik carotid artery / Intima . Intimas : intima media thickness IMT . intima media thickness . carotid artery intima media . musica intima / medias . Medias . MEDIA : Via Acquire Media NewsEdge . SUN MEDIA . FOREIGN MEDIA COVERING SOME * *

Related by context. All words. (Click for frequent words.) 80 carotid artery intima media 78 thickness IMT 78 thickness CIMT 74 intima media thickness 73 intima media thickness IMT 73 carotid IMT 69 LV dysfunction 68 colorectal adenoma 68 morphometric vertebral fractures 68 endometrial thickness 67 nondiabetic patients 67 subclinical atherosclerosis 67 β blockers 67 HOMA IR 66 carotid plaque 66 serum PSA 66 left ventricular dysfunction 66 hip BMD 66 microalbuminuria 66 coronary calcification 66 aspartate aminotransferase AST 66 estimated glomerular filtration 65 ATACAND 65 carotid stenosis 65 intact parathyroid hormone 65 coronary artery calcification 65 left ventricular hypertrophy 65 carotid artery thickness 65 mL/min/#.# m 2 65 nonfatal MI 65 glomerular filtration rate 65 atherogenic dyslipidemia 65 HbA1c levels 65 glycated hemoglobin HbA1c 65 QTc 65 glycosylated hemoglobin HbA1c 65 echocardiographic 65 arterial stiffness 64 glycated hemoglobin levels 64 irbesartan 64 multivariate Cox 64 oral antidiabetic medication 64 carotid arterial 64 troponin T 64 candesartan cilexetil 64 abdominal adiposity 64 periprocedural 64 left ventricular diastolic 64 fasting glucose levels 64 preoperative PSA 64 coronary artery calcium 64 serum triglycerides 64 left ventricular systolic 64 lowest tertile 64 fasting plasma glucose 64 tHcy 64 Lp PLA 2 64 serum CRP 64 fasting insulin 64 VADT 63 intravascular ultrasonography 63 alanine aminotransferase ALT 63 myocardial ischemia 63 abdominal circumference 63 glycated hemoglobin 63 deep venous thromboses 63 C Reactive Protein 63 aminotransferases 63 SCr 63 LDL particle 63 binary restenosis 63 thromboembolic 63 nonfatal myocardial infarction 63 lactate dehydrogenase LDH 63 liver histology 63 LVEF 63 subtrochanteric 63 BENICAR HCT 63 adenoma recurrence 63 postoperative AF 63 prospectively defined 63 corneal curvature 63 urine albumin 63 nicardipine 63 cTnT 63 eplerenone 63 definite stent thrombosis 63 distensibility 63 extrapyramidal symptoms 63 Hb A1C 63 coronary stenosis 63 hemoglobin A1c levels 62 coronary calcium 62 NYHA functional class 62 echocardiographic parameters 62 aortic regurgitation 62 lispro 62 CK MB 62 arteriolar 62 lipid lowering agents 62 hemoglobin A1c HbA1c 62 oxycodone CR 62 highest tertile 62 serum IGF 62 estimated GFR 62 multivariable analysis 62 myocardial infarction stroke 62 ezetimibe simvastatin 62 postintervention 62 recurrent ischemia 62 D dimer 62 Lp PLA2 62 pCR 62 cTnT levels 62 depressive symptomatology 62 univariate analysis 62 tirofiban 62 immunohistochemical 62 STRIDE PD 62 Endothelial function 62 serum estradiol 62 serum urate 62 T2DM 62 confidence interval #.#-#.# 62 alanine aminotransferase 62 angiotensin converting enzyme inhibitor 62 hs CRP 62 symptomatic VTE 62 OGTT 62 TAXUS Express Stent 62 Subgroup analysis 62 hsCRP 62 prespecified secondary 62 diastolic blood pressures 62 Alzheimer Disease Assessment 62 -#.# ± [002] 62 advanced neoplasia 62 serum creatinine levels 62 serum phosphate 62 NPH insulin 62 HER2 expression 62 aspartate aminotransferase 62 CVD mortality 62 Tasigna prolongs 62 CC genotype 62 coronary revascularization 62 baseline serum creatinine 62 logistic regression analysis 62 nonfasting triglyceride levels 62 oral glucose tolerance 62 Hypertrophy 62 creatinine levels 62 osteopenic 62 elevated triglycerides 62 electron beam computed tomography 62 central adiposity 62 N telopeptide 62 histological subtype 62 macroalbuminuria 62 lymph node metastasis 62 detrusor 62 tolvaptan 61 HbA1C 61 arterial stiffening 61 NMIBC 61 ADCS CGIC 61 cTnI 61 Montgomery Åsberg Depression 61 Patency 61 BMI z 61 transthoracic 61 Taxus Stent 61 hypercholesterolaemia 61 overt nephropathy 61 prostate TURP 61 interobserver reliability 61 pretransplant 61 angiotensin converting enzyme 61 renal artery stenosis 61 impaired fasting glucose 61 Carotid artery 61 eptifibatide 61 serum lipid levels 61 achieved statistical significance 61 HbA 1c 61 platelet reactivity 61 P = .# 61 paclitaxel eluting stents 61 ventricular dilatation 61 albuminuria 61 metabolic parameters 61 comorbid conditions 61 XIENCE V PROMUS Stent 61 myocardial uptake 61 eosinophil count 61 multivariable adjusted 61 posttransplant 61 specific antigen PSA 61 glimepiride 61 paricalcitol 61 thromboembolic events 61 arterial thickening 61 nonalcoholic steatohepatitis NASH 61 umbilical artery 61 HbA1C levels 61 euthymic patients 61 pulmonary arterial 61 inotropic 61 multivessel disease 61 leukocyte count 61 Histologic 61 albumin excretion rate 61 cystatin C 61 intratumoral 61 adenoma 61 carotid bruit 61 Microalbuminuria 61 serum lipid 61 flow mediated dilation 61 #.#mg/dL 61 cardiovascular morbidity 61 flutamide 61 mineral density 61 Cystatin C 61 interobserver 61 serum potassium 61 systolic hypertension 61 aminotransferase ALT 61 fasting serum 61 bronchial hyperresponsiveness 61 thromboembolism 61 apolipoprotein B 61 creatinine ratio 61 QT intervals 61 surrogate markers 61 corrected QT interval 61 serum prostate 61 % Confidence Interval 61 elevated ALT 61 serum phosphorous 61 reinfarction 61 ß blockers 61 PCWP 61 elevated LDL cholesterol 61 lipid lowering drugs 61 activated partial thromboplastin 61 Secondary efficacy endpoints 61 PSA nadir 61 myocardial viability 61 radiographic progression 61 antiphospholipid antibodies 61 #.#/#.# mmHg [001] 61 biphasic insulin aspart 61 ADAS Cog 61 infarct size 61 anti JCV antibodies 61 stenoses 61 Severity MSCS score 61 prostate cancer CaP 61 femoral neck BMD 61 Visual Analogue Scale VAS 61 thyroglobulin 61 Skin sterol 61 biochemical recurrence 61 atheroma volume 61 ipsilateral stroke 61 lipid lowering therapy 60 hemoglobin A1C 60 pulmonary capillary wedge 60 macrovascular 60 visceral adiposity 60 serum parathyroid hormone 60 microbleeds 60 nonfasting triglycerides 60 serum BDNF 60 β blocker 60 benazepril 60 metastatic malignant 60 Preoperative 60 stratifying patients 60 alpha blocker 60 myocardial fibrosis 60 Univariate analysis 60 Ranolazine 60 attain statistical significance 60 mild renal insufficiency 60 proteinuria 60 C reactive protein 60 systolic dysfunction 60 NATRECOR ® 60 DES implantation 60 hemodynamically significant 60 Atherosclerotic 60 SUVmax 60 urinary calcium 60 transesophageal echocardiography 60 endometrial hyperplasia 60 QTc prolongation 60 hemodynamic parameters 60 Kaplan Meier analysis 60 Hypotension 60 myocardial infarction MI 60 diabetes mellitus DM 60 bladder carcinoma 60 Angiographic 60 Coronary artery calcification 60 #mmHg [001] 60 HBeAg 60 SGPT 60 intraobserver 60 rosuvastatin #mg 60 cardiovascular hospitalizations 60 occlusive disease 60 glycosylated hemoglobin 60 ABCB1 60 serum bilirubin 60 clinically insignificant 60 induce orthostatic hypotension 60 patients undergoing CABG 60 Albuminuria 60 QRS duration 60 endothelial dysfunction 60 serum ferritin 60 serum aminotransferase levels 60 #mmHg [002] 60 hematopoietic cancers 60 surrogate marker 60 carotid artery stenosis 60 HF hospitalization 60 advanced adenoma 60 microvascular disease 60 sUA 60 pioglitazone HCl 60 exhaled NO 60 carotid artery stenting CAS 60 elevated triglyceride levels 60 posttreatment 60 advanced adenomas 60 postoperative mortality 60 elevated creatinine 60 urinary albumin 60 Scale cognitive subscale 60 SGRQ 60 cardiac dysfunction 60 thiazide diuretics 60 Glomerular Filtration Rate 60 perineural invasion 60 angiotensin converting enzyme ACE 60 hypercalciuria 60 subclinical hypothyroidism 60 revascularizations 60 renal dysfunction 60 Coronary artery calcium 60 glomerular filtration 60 HSCT 60 Index CDAI 60 #.#mmol L [001] 60 fasting glucose 60 nonfatal stroke 60 radical nephrectomy 60 thrombus aspiration 60 NATRECOR R 60 recurrent venous thromboembolism 60 diabetes dyslipidemia 60 Cypher Stent 60 univariate analyzes 60 hyperphenylalaninemia HPA due 60 ejection fractions 60 antibody titer 60 coronary blockages 60 sirolimus eluting stents 60 scintigraphic 60 stent binary restenosis 60 paroxysmal AF 60 International Prostate Symptom 60 inflammatory biomarkers 60 HbA 1c levels 60 lumbar spine bone 60 Carotid intima media 60 intracoronary 60 carotid atherosclerosis 60 perioperative mortality 60 prolonged QT interval 60 rheumatoid factor 60 serum testosterone 60 multivariate adjustment 60 nonsignificant 60 serum urate levels 60 urinary N telopeptide 60 left ventricular LV 60 Thiazolidinediones 60 postoperative complication 60 eGFR 60 beta blocker therapy 60 diameter stenosis 60 onset diabetes mellitus 60 plasma lipids 60 MetS 60 silent myocardial ischemia 60 Events MACE 60 acetabular dysplasia 60 intravenous bisphosphonates 60 albumin excretion 60 rs# [002] 60 graft occlusion 60 peritumoral 60 Endothelial dysfunction 60 revascularisation procedures 60 aspirin clopidogrel 60 Cardiopulmonary bypass 60 Crohn Disease Activity 60 asymptomatic carotid stenosis 60 lumbar spine BMD 60 leiomyomas 60 elevated serum creatinine 60 noncardiac 60 IDDM 60 atherosclerotic disease 60 dyslipidaemia 60 noninferior 60 pioglitazone 59 haematologic 59 biochemical relapse 59 arteriography 59 nonobstructive CAD 59 FFR measurements 59 triglyceride concentration 59 carotid artery blockage 59 FDG uptake 59 PSADT 59 digital subtraction angiography 59 atheroma 59 #mm Hg 59 DAS# [002] 59 fluvastatin 59 Pioglitazone 59 psychiatric comorbidities 59 unfractionated heparin UFH 59 dobutamine 59 tertiles 59 Intracranial 59 fasting lipid 59 preserved ejection fraction 59 colorectal adenomas 59 TT genotype 59 HMG CoA reductase inhibitor 59 urine cytology 59 baroreflex sensitivity 59 apolipoprotein A1 59 anthropometric measures 59 lipid profiles 59 plasma renin activity 59 adenomatous 59 hsCRP levels 59 serum calcium levels 59 transabdominal 59 serum leptin 59 tamsulosin 59 silent ischemia 59 adenotonsillectomy 59 NIHSS 59 #F FDG 59 MGd 59 fasting triglycerides 59 myocardial perfusion 59 multivariable Cox 59 Ki# 59 Carotid 59 GnRH agonist 59 hemodilution 59 myocardial necrosis 59 A2 Lp PLA2 59 transaminase elevations 59 node metastases 59 insulin detemir 59 ventricular mass 59 transient elastography 59 ziprasidone 59 oncologic outcomes 59 macrovascular events 59 lipid parameters 59 carotid plaques 59 candesartan 59 aortic stiffness 59 abciximab 59 PSA kinetics 59 cerebral microbleeds 59 tipranavir r 59 cerebral oxygenation 59 NHANES III 59 dyssynchrony 59 Ejection Fraction 59 Insulin sensitivity 59 LV ejection fraction 59 erythrocyte sedimentation rate 59 Prostate Specific Antigen PSA 59 elevated CRP 59 DAS# CRP 59 mucinous 59 MMSE scores 59 Proteinuria 59 quantitative coronary angiography 59 systemic corticosteroid 59 angiotensin II receptor blockers 59 nonfatal myocardial infarction MI 59 abnormal lipid 59 exhaled nitric oxide 59 ARB telmisartan 59 TAXUS p value 59 olmesartan 59 vascular dysfunction 59 Montgomery Asberg Depression 59 bezafibrate 59 undergone radical prostatectomy 59 antiarrhythmic drug 59 impaired glucose metabolism 59 pT3 59 polyp recurrence 59 multivariate logistic regression 59 cardiac repolarization 59 vertebral fracture 59 isolated systolic hypertension 59 adenomatous polyps 59 baseline FEV 59 Thrombolysis 59 cerebrovascular events 59 dehydroepiandrosterone sulfate 59 macrovascular disease 59 alteplase 59 RVOT 59 covariate 59 Univariate 59 variant angina 59 hypogonadal 59 hyperglycaemia 59 #Gy 59 histopathological 59 azilsartan medoxomil 59 perioperative complications 59 upper gastrointestinal bleeding 59 chlorthalidone 59 systolic BP 59 QTc interval 59 Doxil ® 59 PRADAXA #mg 59 calculated creatinine clearance 59 Primary endpoints 59 mm Stent 59 secondary efficacy endpoint 59 thyrotropin levels 59 autonomic dysfunction 59 serum creatinine 59 thrombophilia 59 preoperatively 59 SLNB 59 hemorrhagic complications 59 fructosamine 59 ultrasonographic 59 chronic thromboembolic pulmonary 59 spirometric 59 â ‰ ¥ 59 eNO 59 metaplasia 59 test OGTT 59 serum triglyceride levels 59 glycosylated hemoglobin levels 59 mammographic density 59 keloid scarring 59 Mean Symptom Complex 59 coronary CTA 59 platelet inhibition 59 metformin sulfonylurea 59 HDL Cholesterol 59 angiographic outcomes 59 HRCT 59 femoral neck 59 cardiometabolic risk 59 severe renal impairment 59 MMSE score 59 calcified plaque 59 intravesical therapy 59 serum lactate 59 serum uric acid 59 gene polymorphisms 59 sulcal 59 atorvastatin #mg 59 tissue oxygenation 59 serum concentrations 59 endometriosis ovarian cysts 59 non valvular atrial 59 Non Alcoholic Steatohepatitis 59 plasma folate 59 NIHSS score 59 prolactin levels 59 extracranial 59 Rating Scale MADRS 59 atypical ductal hyperplasia 59 iodixanol 59 capillary density 59 thrombolytic therapy 59 oral antidiabetic drugs 59 ventricular hypertrophy 59 wedge resection 59 elevated IOP 59 gastric cardia 59 Cardiac Resynchronization 59 Hyperlipidemia 59 artery stenosis 58 HIV HCV coinfected 58 Fractional Flow Reserve 58 loop diuretics 58 hyperintense lesions 58 serum glucose 58 noncalcified 58 serum markers 58 Erythropoietic therapies may 58 plasma homocysteine 58 arterial oxygen saturation 58 creatinine clearance 58 cerebral perfusion 58 SNP rs# [001] 58 Secondary endpoints 58 diastolic function 58 CORE OM 58 hypoperfusion 58 thyrotoxicosis 58 renal impairment 58 troponins 58 dalteparin 58 primary aldosteronism 58 ExTRACT TIMI 58 desvenlafaxine succinate 58 Thromboembolism 58 concomitant medications 58 strontium ranelate 58 loop diuretic 58 Prehypertension 58 multivariate analyzes 58 TEAEs 58 CCyR 58 histopathologic 58 transcranial Doppler ultrasound 58 coronary revascularizations 58 prostate carcinoma 58 core needle biopsies 58 retinal vein occlusion 58 sitosterol 58 prednisone prednisolone 58 periprocedural MI 58 carotid ultrasound 58 angiography CTA 58 nonalcoholic steatohepatitis 58 waist circumference WC 58 lactate dehydrogenase 58 STRATEGY FOR AN OPEN 58 dapagliflozin plus 58 postoperative chemotherapy 58 calcified plaques 58 hydroxyvitamin D concentrations 58 Avandia Actos 58 antidiabetic medications 58 STN stimulation 58 statistically significant p = 58 oral hypoglycemic agents 58 Stent thrombosis 58 nonischemic 58 rs# [001] 58 primary percutaneous coronary 58 proliferative diabetic retinopathy 58 #mg/day [001] 58 Crestor rosuvastatin 58 ACE Inhibitor 58 #mg BID [001] 58 APOC3 58 fibrinolysis 58 thrombus formation 58 BENICAR 58 Nesiritide 58 mitral annular 58 lipid lowering medications 58 Breslow thickness 58 mcg QD 58 postprocedure 58 Bone Mineral Density 58 Waist Circumference 58 cranial irradiation 58 death reinfarction 58 hypercoagulable 58 HMG CoA reductase inhibitors 58 protein excretion 58 preintervention 58 TAXUS Stent 58 lipoprotein levels 58 epicardial adipose tissue 58 aminotransferase levels 58 plasma triglycerides 58 fraction LVEF 58 everolimus eluting stents 58 ACTOS ® 58 myeloperoxidase 58 ipsilateral 58 univariate 58 colesevelam HCl 58 creatine kinase MB 58 stable angina 58 Secondary endpoints included 58 BMI waist circumference 58 arrhythmogenic 58 statistical significance p 58 platelet activation 58 parathyroidectomy 58 perimenopausal women 58 overt hypothyroidism 58 normotensive 58 density lipoprotein cholesterol 58 microvessel 58 placebo p = 58 rs# [003] 58 tapentadol ER 58 AST ALT 58 HER2 overexpression 58 peptide BNP 58 prognostic significance 58 serum cortisol 58 bioavailable testosterone 58 lipoprotein Lp 58 achieved ACR# 58 MADRS score 58 tibolone 58 QTc intervals 58 glulisine 58 corneal thickness 58 undergoing coronary angiography 58 airway hyperresponsiveness 58 prospective multicentre 58 mg BID dose 58 histopathologic examination 58 CTEPH 58 somatostatin analog 58 clinically meaningful improvement 58 fasting plasma 58 #mg/dL [001] 58 composite endpoint 58 #mg/dL [002] 58 Doppler echocardiography 58 axillary lymph node 58 genotypic resistance 58 TNF Tumor Necrosis Factor 58 transurethral resection 58 reflux esophagitis 58 LVSD 58 galiximab 58 cardiovascular mortality 58 cardiovascular hospitalization 58 XIENCE V vs. 58 Postoperative 58 primary hyperparathyroidism 58 atherosclerotic lesion 58 DEXA scan 58 salmeterol fluticasone propionate 58 EBUS FNA 58 Psoriasis Area 58 elevated homocysteine 58 Prospective Randomized 58 CI -#.# 58 DAPT 58 antihypertensive therapy 58 Coronary Artery Bypass Graft 58 ventricular remodeling 58 nitrotyrosine 58 -#.# mg dL [001] 58 Response Evaluation Criteria 58 retinal thickness 58 chronic periodontitis 58 Pegylated Liposomal Doxorubicin 58 tumor necrosis 58 ovarian carcinoma 58 esophageal varices 58 imatinib therapy 58 CLA supplementation 58 neurologic progression 58 hemoglobin Hb 58 insulin glargine 58 mm Hg diastolic 58 NIDDM 58 hydroxychloroquine 58 clinically meaningful reductions 58 ACTOplus met 58 hypertensives 58 Subarachnoid hemorrhage 58 PAOD 58 QT interval 58 creatine kinase 58 myocardial reperfusion 58 inhaled budesonide 58 #q# deletion syndrome 58 dose clopidogrel 58 Hemodynamic 58 mineral density BMD 58 grade cervical intraepithelial 58 afterload 58 plasma lipid 58 CP CPPS 58 vasomotor 58 lymphadenectomy 58 TNF blocker therapy 58 complete cytogenetic response 58 comorbidity 58 antihypertensive medications 58 valsartan 58 extracapsular extension 58 logistic regression model 58 atherothrombotic events 58 myocardial infarction 58 dysfunction LVSD 58 SHBG levels 58 hematological parameters 58 hyperinsulinemic euglycemic clamp 58 T2 lesions 58 cilostazol 58 cardiac troponin 58 central corneal thickness 58 diastolic hypertension 58 serum ALT 58 2 diabetes T2D 58 p = NS 58 GH deficiency 58 GSTP1 58 nadolol 58 waist circumference 58 XIENCE V demonstrated 58 angioplasty stenting 58 aldosterone antagonist 58 IL#B 58 calcium antagonists 58 tertile 58 cardiac contractility 58 #mg doses [002] 58 plasminogen activator inhibitor 58 Metastatic Prostate Cancer 58 colorectal carcinoma 58 Abciximab 58 PREZISTA r arm 58 pravastatin 58 leukocyte counts 58 liver metastasis 58 urothelial carcinoma 58 triglyceride concentrations 58 angiographically 58 esophagogastroduodenoscopy 58 QRS interval 58 TRAIL R1 58 sirolimus stent 58 arterial thromboembolic events 58 methotrexate monotherapy 58 receiving VELCADE 57 Scale EDSS 57 ASTEROID 57 relapsed MM 57 5 Fluorouracil 57 antidiabetic medication 57 HbA1c 57 inhibin B 57 prostate carcinogenesis 57 nondiabetics 57 moderate renal impairment 57 racemic albuterol 57 plasma leptin 57 angiotensin receptor blocker ARB 57 diuretic hydrochlorothiazide 57 systolic diastolic 57 antiplatelet drugs 57 elevated troponin 57 detemir 57 luminal diameter 57 Main Outcome Measure 57 nonvertebral fracture 57 antigen PSA 57 ACE inhibitor ramipril 57 coagulation abnormalities 57 TAXUS Liberte Long 57 refractory ischemia 57 HGPIN 57 ug dose 57 carcinoembryonic antigen 57 histologic 57 Adenomas 57 severe neutropenia 57 androgen deficiency 57 ertapenem 57 antral 57 intravascular hemolysis 57 amisulpride 57 chest radiography 57 oral antidiabetes 57 Myocardial 57 postoperative morbidity 57 nephron sparing surgery 57 mm Hg systolic 57 osteochondroma 57 postmenopausal osteoporotic women 57 serum calcium 57 Logistic regression 57 HDL cholesterol triglycerides 57 apolipoproteins 57 SGOT 57 ductal cancer 57 Ramipril 57 renal insufficiency 57 elevated transaminases 57 chest radiographs 57 cisplatin vinorelbine 57 DMARD 57 myocardial infarctions 57 dose atorvastatin 57 locoregional recurrence 57 % CI #.#-#.# [006] 57 abacavir lamivudine 57 clinico pathological 57 % CI #.#-#.# [001] 57 cardiac troponin T 57 peak VO2 57 salmeterol HFA MDI 57 plasma selenium 57 maternal serum 57 plasma pharmacokinetics 57 radical prostatectomy RP 57 antihypertensive drugs 57 IPSS 57 pericardial fat 57 euthyroid 57 hemodynamics 57 WOMAC pain 57 neointimal hyperplasia 57 systemic hypotension 57 Hypertriglyceridemia 57 Percutaneous Coronary Intervention 57 thiazide 57 postoperative pulmonary 57 INCB# [003] 57 xanthine oxidase inhibitor 57 GP IIb IIIa inhibitors 57 baseline HbA1c 57 Score IPSS 57 primary hypercholesterolemia 57 prespecified 57 incomplete revascularization 57 LDL cholesterol HDL cholesterol 57 urate lowering therapy 57 endoleak 57 Score TOS 57 FOLFOX6 57 plasma uric acid 57 virologic failure 57 serum folate 57 Diovan HCT 57 NNT = 57 PLX STROKE targeting 57 pioglitazone Actos 57 urothelial 57 contrast induced nephropathy 57 Forced expiratory volume 57 statistically nonsignificant 57 levosimendan 57 x ULN 57 MACCE 57 CARE HF 57 methacholine challenge 57 VIIBRYD 57 radial artery grafts 57 asthma exacerbation 57 androgen deprivation 57 thienopyridines 57 NYHA Class III 57 CrCl 57 albumin creatinine ratio 57 epididymal 57 prospectively evaluated 57 telomere lengths 57 undetectable HBV DNA 57 IL6 57 L thyroxine 57 antipsychotic efficacy 57 CANCIDAS 57 gastric carcinoma 57 adrenalectomy 57 lopinavir r arm 57 PD2i R 57 APTIVUS r 57 multivariable analyzes 57 Clusterin 57 metabolic disturbances 57 fasting plasma glucose FPG 57 urinary excretion 57 recurrent VTE 57 #.#ng/ml 57 radioimmunoassay 57 transaminase levels 57 Fasting glucose

Back to home page